Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.
36 results about "GroEL" patented technology
Filter
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
GroEL belongs to the chaperonin family of molecular chaperones, and is found in many bacteria. It is required for the proper folding of many proteins. To function properly, GroEL requires the lid-like cochaperonin protein complex GroES. In eukaryotes the proteins Hsp60 and Hsp10 are structurally and functionally nearly identical to GroEL and GroES, respectively.
The invention discloses a fusion protein, the amino acid sequence of which contains an iRGD peptide sequence shown as SEQ ID No:1 and a molecular chaperone GroEL sequence shown as SEQ ID No:2. The invention further discloses an encoding gene of the fusion protein, the sequence of which is a nucleotide sequence capable of encoding the fusion protein. The invention further discloses a preparation method of the fusion protein. The preparation method comprises the following step of expressing the encoding gene in a bacterial strain to obtain the fusion protein. A method of preparing a pharmaceutical composition comprises the following steps of contacting the pharmaceutical compound with the fusion protein disclosed by the invention to obtain a contacted material in the presence of a solvent. The invention further discloses the pharmaceutical composition prepared by the method of preparing the pharmaceutical composition. The fusion protein provided by the invention can stably load a hydrophobic drug, and is high in drug-carrying efficiency and good in drug release effect. The pharmaceutical composition prepared by the fusion protein provided by the invention has the advantages of good biocompatibility and good drug release effect.
The invention provides a protein separation device comprising a chaperone protein immobilised on a substrate. In one embodiment, the chaperone protein is an Hsp60 chaperone, preferably a group one chaperone, preferably GroEL. The invention also provides a method for isolating a protein from a biological sample using a protein separation device of the invention.
The invention discloses a bacterial cellulose producing strain and an identification method thereof. The strain is named as Komagataeibacter sp.171129Z2-3, the strain is preserved in the China General Microbiological Culture Collection Center (CGMCC), and the preservation number is CGMCC No.17276. The strain is gram-negative and short-rod-shaped bacteria, has the characteristics of wide selection range of a carbon source and a nitrogen source, high growth speed, strong thallus activity, strong cellulose production capacity and the like, can produce a large amount of bacterial cellulose during static culture and shake culture, and can achieve the yields of 5.12 g / L and 2.571 g / L after 4 days of fermentation respectively. Through physiological and biochemical characteristics, 16SrDNA, dnaK, groEL and rpoBgenesequence analysis and genome average nucleotide index (ANI) analysis, the strain is determined to be foal bacillus. The strain has a good implementation prospect in the aspect of industrial production of the bacterial cellulose.
The invention provides a preparation method of protein nanocage stabilized Pickering emulsion in order to overcome defects that nano-particle stabilized Pickering emulsion is poor in biocompatibilityand biodegradability and common bioorganic molecules are poor in surface activity, have insufficient monodispersity and wetting performance and are easily affected by environmental conditions, and belongs to the field of Pickering emulsion. According to a specific scheme, a buffer solution of a GroELprotein nanocage is prepared, and mass fraction of GroEL is controlled to be 0.05wt%-0.45wt%; an oil-phase substance and water are mixed in a certain proportion, and the range of a volume ratio of the oil-phase substance to water is controlled to be 0.11-0.50; the GroEL solution is added to an oil-water mixture dropwise, meanwhile, the mixture is stirred, ultrasonic treatment is performed, and crude emulsion is enabled to be homogenized. The invention further provides an application of the Pickering emulsion as a bioactive substance for carrier encapsulating or transport. The Pickering emulsion prepared on the basis of the unique structure and excellent interfacial activity of GroEL has the advantages of good stability, long quality guarantee period, high biocompatibility and simple preparation process and is environmentally friendly.
The invention discloses a heme-GroEL complex and a preparation method and application thereof. The heme-GroEL complex is provided with two back-to-back cavities. The inner surface at an opening of each cavity is provided with seven hydrophobic grooves perpendicular to the center line of the cavity. Each cavity can be combined with a plurality of monomerheme molecules through hydrophobic interaction. The heme-GroEL complex is good in stability, has the significant catalase activity, can be used instead of natural peroxidase, can be used for chromogenic detection of hydrogenperoxide or glucose, and can be also used for detection or oxidation removal of phenolic pollutants.
The invention belongs to the field of genetic breeding, and in particular relates to a simple Arthrobactermutant strain with stress tolerance and a genetic engineering bacterium constructed therefrom. Among them, the survival rate of the mutant strains under 16% ethanol and 20% methanol shock conditions increased by 3.74 times and 2.10 times respectively compared with the starting strain; overexpression of groEL, dnaK, recA, uvrD, katG, sod or treS genes from the mutant strains The tolerance of the engineered bacteria to high concentrations of organic solvents is significantly improved, and they also show higher tolerance to salt stress and oxidative stress. The above engineered bacteria are used in the steroid C1,2 dehydrogenation reaction to put The ethanol concentration was increased to 8-10%, the substrate CA concentration was increased to 6-8g / L, and the product yield was increased by 0.41-3.56 times, which laid a good foundation for the subsequent research on the resistance mechanism and the molecular transformation and application of strains.
The invention belongs to the technical field of feed biology, and discloses an enzyme and bacterium functional bag capable of rapidly degrading soybean meal antigens and application of the enzyme and bacterium functional bag. The functional package comprises alkaline protease AlkP-S1mut subjected to triple mutation through an S1 pocket and thermophilic probioticbacillus licheniformis BL-TH01, the alkaline protease AlkP-S1mut and the thermophilic probioticbacillus licheniformis BL-TH01 are loaded in a microporous starch-sodium alginate composite carrier and have a synergistic effect at the temperature of 30-45 DEG C, and the degradation rate of beta-conglycinin is larger than or equal to 95% within 2 hours. A molecular chaperone GroEL-BL is used for inducing antigen conformation to loosen and exposing restriction enzymecutting sites, and mutationprotease is accurately hydrolyzed, so that nutrient loss and bitter taste generation are avoided. According to the invention, a high-efficiency, energy-saving and high-fidelity bean pulp antigen degradation system is constructed through a dual strategy of genetic engineering modification and microbial synergy. The system breaks through the natural limitation of a single enzyme preparation, realizes normal form transformation from passive waiting for substrate exposure to active induction of substrate opening, and provides a technical solution with economical efficiency and sustainability for the feed industry.
The application belongs to the technical field of genetic engineering, and particularly relates to a genetically engineered bacterium with high expression of clostridial protease and application thereof. The genetically engineered bacterium provided by the application co-expresses clostridial protease and a molecular chaperone; the molecular chaperone is GroEL and KAR2; the nucleotide sequence of the clostridial protease is shown as SEQ ID NO. 2; and the molecular chaperone has the nucleotide sequences shown as SEQ ID NO. 6 and SEQ ID NO. 10. The genetically engineered bacterium with co-expression of clostridial protease and a molecular chaperone provided by the application enables efficient expression of Arg-C in a soluble form, thereby efficiently and stably producing Arg-C. The obtained Arg-C can decompose complex proteins into specific peptide segments, so that the presence and content of a marker can be more accurately determined.
The present invention is based on the shuttle vector between radioresistant bacteria and Escherichia coli, and is recombined with the active groELpromoter and canine CaIFN-α gene fragment derived from the radioresistant bacteriaDeinococcus radiodurans to construct a plasmid with CaIFN-α expression activity. The radioresistant bacterium Deinococcus grandis was used as the host, induced by -rayirradiation, etc., to efficiently express and produce canine CaIFN-α with biological activity. The present invention better solves the complex renaturation operation required for the expression of canine CaIFN-α in Escherichia coli, the instability of plasmid transformants in yeast expression, the high cost of expression and production in mammalian cultured cells, and the need for expression in silkworm larvae. Due to seasonal restrictions, the disadvantage of not being able to produce on an annual basis.
The invention relates to a streptococcus agalactiae amplification primer group, an application and a detection method of streptococcus agalactiae, and belongs to the technical field of microbiologicaldetection. The detection method of streptococcus agalactiae comprises the following steps: 1) designing an MCDA amplification primer group of specific genes groEL: CP1, CP2, F1, F2, D1 *, D2, C1, C2,R1 * and R2; 2) in a reaction system comprising the amplification primer group, taking a genome of a streptococcus agalactiae sample to be detected as a template, and performing MCDA constant-temperature amplification to obtain an amplification product; and 3) detecting the amplification product in the step 2) by using a gold nano biosensor to obtain a detection result. According to the method, on the basis of multi-cross constant-temperature amplification and in combination with a nano-biological detection technology, the streptococcus agalactiae can be directly, quickly, sensitively and highly-specifically detected and identified from clinical samples.
The invention provides a protein separation device comprising a chaperone protein immobilized on a substrate. In one embodiment, the chaperone protein is an Hsp60 chaperone, preferably a group one chaperone, preferably GroEL. The invention also provides a method for isolating a protein from a biological sample using a protein separation device of the invention.